Total liabilities · 2019–2025

Royalty Pharma total liabilities

$9.9B+25.7% · FY2025

Royalty Pharma (RPRX) reported $9.9B in total liabilities for fiscal 2025, +25.7% year on year.

$6.3B2019$6.1B2020$7.3B2021$7.3B2022$6.3B2023$7.9B2024$9.9B2025
Royalty Pharma — Total liabilities, 2019–2025
Fiscal yearTotal liabilitiesChangeFiling
FY20252025-12-31$9.9B+25.7%Open →
FY20242024-12-31$7.9B+25.1%Open →
FY20232023-12-31$6.3B−13.6%Open →
FY20222022-12-31$7.3B+0.3%Open →
FY20212021-12-31$7.3B+18.7%Open →
FY20202020-12-31$6.1B−2.9%Open →
FY20192019-12-31$6.3B—Open →

Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +7.8%

Total liabilities at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Royalty Pharma total liabilities |url=https://companiesranked.com/en/company/royalty-pharma/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Royalty Pharma total liabilities. CompaniesRanked. https://companiesranked.com/en/company/royalty-pharma/total-liabilities

BibTeX

@misc{companiesranked-en-company-royalty-pharma-total-liabilities-2026,
  author       = {{CompaniesRanked}},
  title        = {{Royalty Pharma total liabilities}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/royalty-pharma/total-liabilities}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001802768-26-000015 · August 5, 2026

{{cite web |title=Royalty Pharma total liabilities — 10-Q (0001802768-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1802768/000180276826000015/rprx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Royalty Pharma overview